Alliance Pharma | City of London Investment Group | ELECO | Empresaria | Futura Medical | Grafenia | Lombard Risk Management | MedicX Fund | Murgitroyd | PPHE | Primary Health Properties | R.E.A. Holdings | Sanderson | Tethys Oil AB | United Cacao Limited SEZC | Verona Pharma
02 Jun 2015
June 2015 Monthly - Accounting Issues For Investors – An Occasional Series – Part 1
Alliance Pharma plc (APH:LON), 34.9 | City of London Investment Group PLC (CLIG:LON), 338 | Eleco Plc (ELCO:LON), 97.0 | Empresaria Group plc (EMR:LON), 38.0 | Futura Medical plc (FUM:LON), 36.0 | Software Circle PLC (SFT:LON), 19.0 | Lombard Risk Management (LRM:LON), 0 | Medicx Fund (MXF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | PPHE Hotel Group Limited (PPH:LON), 1,520 | United Cacao Ltd Sezc (CHOC:LON), 0 | Primary Health Properties PLC (PHP:LON), 91.9 | Tethys Oil AB (0A1V:LON), 0 | Sondrel (Holdings) Ltd. (SND:LON), 4.2 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
June 2015 Monthly - Accounting Issues For Investors – An Occasional Series – Part 1
Alliance Pharma plc (APH:LON), 34.9 | City of London Investment Group PLC (CLIG:LON), 338 | Eleco Plc (ELCO:LON), 97.0 | Empresaria Group plc (EMR:LON), 38.0 | Futura Medical plc (FUM:LON), 36.0 | Software Circle PLC (SFT:LON), 19.0 | Lombard Risk Management (LRM:LON), 0 | Medicx Fund (MXF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | PPHE Hotel Group Limited (PPH:LON), 1,520 | United Cacao Ltd Sezc (CHOC:LON), 0 | Primary Health Properties PLC (PHP:LON), 91.9 | Tethys Oil AB (0A1V:LON), 0 | Sondrel (Holdings) Ltd. (SND:LON), 4.2 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
- Published:
02 Jun 2015 -
Author:
Mike Foster -
Pages:
23
Alliance Pharma | City of London Investment Group | ELECO | Empresaria | Futura Medical | Grafenia | Lombard Risk Management | MedicX Fund | Murgitroyd | PPHE | Primary Health Properties | R.E.A. Holdings | Sanderson | Tethys Oil AB | United Cacao Limited SEZC | Verona Pharma